Inventor
DOHERTY DANIEL H
US27 patents
⚠️ This page may combine multiple inventors who share the name “DOHERTY DANIEL H”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BOLDER BIOTECHNOLOGY INC
7 patentsUS6753165B1Jun 22, 2004
Methods for making proteins containing free cysteine residues
BOLDER BIOTECHNOLOGY INC144 citations98
US7824669B2Nov 2, 2010
In vivo stimulation of peripheral blood progenitor cells by granulocyte-macrophage colony stimulating factor (GM-CSF) cysteine muteins and their PEGylated variants
BOLDER BIOTECHNOLOGY INC12 citations92
US7754855B1Jul 13, 2010
Immunoglobulin fusion proteins
BOLDER BIOTECHNOLOGY INC24 citations92
US7306931B2Dec 11, 2007
Method for refolding proteins containing free cysteine residues
BOLDER BIOTECHNOLOGY INC38 citations92
US7153943B2Dec 26, 2006
Derivatives of growth hormone and related proteins, and methods of use thereof
BOLDER BIOTECHNOLOGY INC29 citations92
US7947655B2May 24, 2011
Methods for making proteins containing free cysteine residues
BOLDER BIOTECHNOLOGY INC9 citations84
US7560101B2Jul 14, 2009
Method of treatment of an infection in an animal with GM-CSF cysteine muteins in the proximal region to helix A
BOLDER BIOTECHNOLOGY INC11 citations84
AMGEN INC
6 patentsUS6015572AJan 18, 2000
Implantable device containing GDNF secreting cells for treating nerve damage and methods of use
AMGEN INC137 citations98
US7226758B1Jun 5, 2007
Nucleic acids encoding glial cell line-derived neurotrophic factor (GDNF)
AMGEN INC43 citations95
US5935795AAug 10, 1999
Glial cell line-derived neurotrophic factor antibody
AMGEN INC35 citations95
US6362319B1Mar 26, 2002
Glial cell line-derived neurotrophic factor
AMGEN INC22 citations92
US6221376B1Apr 24, 2001
Glial cell line-derived neurotrophic factor
AMGEN INC21 citations92
US6093802AJul 25, 2000
Glial cell line-derived neurotrophic factor
AMGEN INC14 citations81